Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 10.8B | 10.2B | 11.1B | 10.1B |
Cost of revenue | 1.8B | 1.7B | 2.0B | 2.3B |
Gross profit | 9.0B | 8.5B | 9.1B | 7.8B |
Operating expense | ||||
Research & development | 2.7B | 2.4B | 3.5B | 2.3B |
Selling general and admin | 3.7B | 3.5B | 4.1B | 4.0B |
Other operating expenses | -59.0M | — | — | — |
Operating income | 2.6B | 2.7B | 1.5B | 1.6B |
Non operating interest income | ||||
Income | 50.8M | 62.8M | 47.8M | 136.7M |
Expense | 328.0M | 260.7M | 320.5M | 341.4M |
Other income expense | — | — | — | — |
Pretax income | 2.3B | 2.5B | 1.2B | 1.4B |
Tax provision | 507.3M | 359.4M | 124.0M | 295.1M |
Net income | 1.8B | 2.2B | 1.1B | 1.1B |
Basic EPS | 1.6 | 1.9 | 1.0 | 0.9 |
Diluted EPS | 1.6 | 1.9 | 1.0 | 0.9 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 3.7B | 3.8B | 2.1B | 3.1B |
Net income from continuing op. | 2.3B | 2.5B | 1.2B | 1.4B |
Minority interests | 1.5M | -3.7M | 0 | -3.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |